痰热清联合阿奇霉素治疗小儿支原体肺炎的疗效及安全性

目的：探究痰热清注射液与阿奇霉素联合治疗小儿支原体肺炎的临床疗效.方法：选取我院 2015年7月 -2016年7月收治的80例支原体患儿作为研究对象,采用随机抽样方法将80例患儿平均分为两组,一组为对照组另一组为观察组,每组分别有40例患儿.对照组采用阿奇霉素序贯疗法治疗;观察组在对照组的基础上给予痰热清注射液静脉注射,分析两组患儿治疗后临床疗效.结果：观察组患儿临床表现症状消失时间明显快于对照组;且治疗后观察组总有效率为 97.50% 明显高于对照组的 80.00%,两组差异具有统计学意义（P〈0.05）.结论：痰热清注射液联合阿奇霉素治疗治疗小儿支原体肺炎的疗效显著.

Objective： To explore the clinical efficacy Tanreqing injection with azithromycin treatment of children with mycoplasma pneumonia. Methods： in our hospital in July 2015 --80 patients treated mycoplasma in July 2016 as the research object, using random sampling of 80 patients were divided into two groups, one group to another control group was observed groups of 40 patients each. The control group was azithromycin sequential therapy; observation group Tanreqing injection intravenously in the control group based on the analysis of the clinical efficacy of the treatment of two groups of children. Results： The clinical manifestations in children symptoms disappeared time was significantly faster than the control group; and the post-treatment observation group total effective rate of 97.50% was significantly higher than 80.00%, the difference was statistically significant （P 〈0.05）. Conclusion： Tanreqing efficacy of combination therapy with azithromycin treatment of children with mycoplasma pneumonia significantly.